Cryptosporidium parvum: The contribution of Th1-inducing pathways to the resolution of infection in mice

Experimental Parasitology - Tập 115 - Trang 107-113 - 2007
Humphrey N. Ehigiator1,2, Nina McNair1, Jan R. Mead1,2
1Veterans Affairs Medical Center, Medical Research 151, 1670 Clairmont Road, Decatur, GA 30033, USA
2Emory University School of Medicine, Department of Pediatrics, Atlanta, Georgia 30322, USA

Tài liệu tham khảo

Arrowood, 1996, Improved purification methods for calf-derived Cyrptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients, Journal of Eukaryotic Microbiology, 43, 89S, 10.1111/j.1550-7408.1996.tb05015.x Arrowood, 1995, A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry, Journal of Parasitology, 81, 404, 10.2307/3283822 Artis, 2004, Early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection, Journal of Immunology, 172, 4672, 10.4049/jimmunol.172.8.4672 Bohn, 1998, IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice, Journal of Immunology, 160, 299, 10.4049/jimmunol.160.1.299 Cai, 2000, IL-18 enhances innate IL-12-mediated resistance to Toxoplasma gondii, Infection and Immunity, 68, 6932, 10.1128/IAI.68.12.6932-6938.2000 Campbell, 2002, Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice, Journal of Parasitology, 88, 1014, 10.1645/0022-3395(2002)088[1014:STCPII]2.0.CO;2 Canals, 1998, Local ileal cytokine responses in cattle during a primary infection with Cryptosporidium parvum, Journal of Parasitology, 84, 125, 10.2307/3284541 Cooper, 1997, Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacteria tuberculosis, Journal of Experimental Medicine, 186, 39, 10.1084/jem.186.1.39 Cooper, 2002, Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present, Journal of Immunology, 168, 1322, 10.4049/jimmunol.168.3.1322 Culshaw, 1997, Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production, Infection and Immunity, 65, 3074, 10.1128/IAI.65.8.3074-3079.1997 Dann, 2005, Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium, Journal of Infectious Disease, 192, 1294, 10.1086/444393 Decken, 1998, Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptocococcus neoformans, Infection and Immunity, 66, 4994, 10.1128/IAI.66.10.4994-5000.1998 Egger, 1990, Symptoms and transmissions of intestinal cryptosporidiosis, Archives of Diseases in Childhood, 65, 45, 10.1136/adc.65.4.445 Ehigiator, 2003, IL-12 knockout C57BL/6 mice are protected from re-infection with Cryptosporidium parvum after challenge, Journal of Eukaryotic Microbiology, 50, S539, 10.1111/j.1550-7408.2003.tb00622.x Ehigiator, 2005, Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice, Parasite Immunology, 50, 17, 10.1111/j.1365-3024.2005.00736.x Gavrilescu, 2003, Interleukin-12 p40- and Fas Ligand-dependent apoptotic pathways involving Stat-1 phosphorylation are triggered during infection with a virulent strain of Toxoplasma gondii, Infection and Immunity, 75, 2577, 10.1128/IAI.71.5.2577-2583.2003 Gazzinelli, 1994, Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii, Journal of Immunology, 153, 2533, 10.4049/jimmunol.153.6.2533 Gollob, 1999, The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation, Journal of Immunology, 162, 4472, 10.4049/jimmunol.162.8.4472 Gomez-Morales, 1999, Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis, Journal of Infectious Diseases, 179, 967, 10.1086/314665 Griffiths, 1998, The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum, Journal of Clinical Microbiology, 36, 2503, 10.1128/JCM.36.9.2503-2508.1998 Grohmann, 1998, IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production, Immunity, 9, 315, 10.1016/S1074-7613(00)80614-7 Guerrant, 1997, Cryptosporidiosis: an emerging, highly infectious threat, Emerging Infectious Diseases, 3, 51, 10.3201/eid0301.970106 Hook, 2005, Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells, FEMS Immunology and Medical Microbiology, 45, 113, 10.1016/j.femsim.2005.02.010 Hoxie, 1997, Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin, American Journal of Public Health, 87, 2032, 10.2105/AJPH.87.12.2032 Hsieh, 1993, Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547, 10.1126/science.8097338 Kaplan, 1996, Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice, Nature, 382, 174, 10.1038/382174a0 Kawakami, 2002, Interleukin-18 and host defense against infectious pathogens, Journal of Immunotherapy, 25, S12, 10.1097/00002371-200203001-00003 Kawakami, 1997, IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production, Journal of Immunology, 159, 5528, 10.4049/jimmunol.159.11.5528 Kawakami, 2000, IL-18 contributes to host resistance against infection with Cryptocococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK cells, Journal of Immunology, 165, 941, 10.4049/jimmunol.165.2.941 Lieberman, 2004, IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12, Journal of Immunology, 173, 1887, 10.4049/jimmunol.173.3.1887 Lieberman, 2004, Stat1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during Toxoplasmosis, Journal of Immunology, 172, 457, 10.4049/jimmunol.172.1.457 McDonald, 2004, Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines, Journal of Infectious Diseases, 190, 1019, 10.1086/422761 Mead, 1998, Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice, Journal of Parasitology, 84, 1045, 10.2307/3284643 Meraz, 1996, Targeted disruption in the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell, 84, 431, 10.1016/S0092-8674(00)81288-X Okazawa, 2004, Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes, Clinical and Experimental Immunology, 136, 269, 10.1111/j.1365-2249.2004.02431.x Oxenius, 1999, IL-12 is not required for induction of type 1-cytokine responses in viral infections, Journal of Immunology, 162, 965, 10.4049/jimmunol.162.2.965 Qureshi, 1999, Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptocococcus neoformans, European Journal of Immunology, 29, 643, 10.1002/(SICI)1521-4141(199902)29:02<643::AID-IMMU643>3.0.CO;2-E Riggs, 2002, Recent advances in cryptosporidiosis: the immune response, Microbes and Infection, 4, 1067, 10.1016/S1286-4579(02)01631-3 Robinson, 2000, Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans, Infection and Immunity, 68, 5405, 10.1128/IAI.68.9.5405-5407.2000 Robinson, 2001, Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection, Cytokine, 15, 39, 10.1006/cyto.2001.0888 Singh, 2005, Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis, American Journal of Physiology – Gastrointestinal and Liver Physiology, 288, 514, 10.1152/ajpgi.00377.2004 Smith, 2000, Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice, Journal of Parasitology, 86, 300, 10.1645/0022-3395(2000)086[0300:CEASLP]2.0.CO;2 Smith, 2001, Exogenous Interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice, Experimental Parasitology, 98, 123, 10.1006/expr.2001.4627 Takeda, 2003, Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment, Journal of Immunology, 170, 4886, 10.4049/jimmunol.170.10.4886 Theodos, 1997, Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection, Infection and Immunity, 65, 4761, 10.1128/IAI.65.11.4761-4769.1997 Thierfelder, 1996, Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells, Nature, 382, 171, 10.1038/382171a0 Tilley, 1995, Resolution of cryptosporidial infection in mice correlates with parasite-specific lymphocyte proliferation associated with both Th1 and Th2 cytokine secretion, Parasite Immunology, 17, 459, 10.1111/j.1365-3024.1995.tb00915.x Urban, 1996, IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum, Journal of Immunology, 156, 263, 10.4049/jimmunol.156.1.263 Wei, 1999, Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice, Journal of Immunology, 163, 2821, 10.4049/jimmunol.163.5.2821